The acute HIV infection: Implications for intervention, prevention and development of an effective AIDS vaccine

Current Opinion in Virology

Volumn 1, Issue 3, 2011, Pages 204-210

  Nishimura, Yoshiaki ^a   Martin, Malcolm A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; TENOFOVIR;

ANTIBODY TITER; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INOCULATION; LYMPH NODE CELL; MEMORY T LYMPHOCYTE; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 80052216693     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2011.05.007     Document Type: Review

References (47)

1. Q. Abdool Karim, S.S. Abdool Karim, J.A. Frohlich, A.C. Grobler, C. Baxter, L.E. Mansoor, A.B. Kharsany, S. Sibeko, K.P. Mlisana, and Z. Omar Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 2010 1168 1174
2. S. Rerks-Ngarm, P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris, N. Premsri, C. Namwat, M. de Souza, and E. Adams Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N Engl J Med 361 2009 2209 2220
3. N. Gasper-Smith, D.M. Crossman, J.F. Whitesides, N. Mensali, J.S. Ottinger, S.G. Plonk, M.A. Moody, G. Ferrari, K.J. Weinhold, and S.E. Miller Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design J Virol 82 2008 7700 7710 (Pubitemid 352031235)
4. A.T. Haase Early events in sexual transmission of HIV and SIV and opportunities for interventions Annu Rev Med 62 2011 127 139
5. A.J. McMichael, P. Borrow, G.D. Tomaras, N. Goonetilleke, and B.F. Haynes The immune response during acute HIV-1 infection: clues for vaccine development Nat Rev Immunol 10 2010 11 23
6. J. Hu, M.B. Gardner, and C.J. Miller Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells J Virol 74 2000 6087 6095 (Pubitemid 30412980)
7. C.J. Miller, Q. Li, K. Abel, E.Y. Kim, Z.M. Ma, S. Wietgrefe, L. La Franco-Scheuch, L. Compton, L. Duan, and M.D. Shore Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus J Virol 79 2005 9217 9227 (Pubitemid 40934833)
8. Z. Zhang, T. Schuler, M. Zupancic, S. Wietgrefe, K.A. Staskus, K.A. Reimann, T.A. Reinhart, M. Rogan, W. Cavert, and C.J. Miller Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells Science 286 1999 1353 1357
9. A.T. Haase Targeting early infection to prevent HIV-1 mucosal transmission Nature 464 2010 217 223
10. K. Abel, D.M. Rocke, B. Chohan, L. Fritts, and C.J. Miller Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection J Virol 79 2005 12164 12172 (Pubitemid 41346078)
11. Q. Li, J.D. Estes, P.M. Schlievert, L. Duan, A.J. Brosnahan, P.J. Southern, C.S. Reilly, M.L. Peterson, N. Schultz-Darken, and K.G. Brunner Glycerol monolaurate prevents mucosal SIV transmission Nature 458 2009 1034 1038
12. Y. Endo, T. Igarashi, Y. Nishimura, C. Buckler, A. Buckler-White, R. Plishka, D.S. Dimitrov, and M.A. Martin Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus J Virol 74 2000 6935 6945 (Pubitemid 30470676)
13. V.M. Hirsch, and P.R. Johnson Pathogenic diversity of simian immunodeficiency viruses Virus Res 32 1994 183 203 (Pubitemid 24147716)
14. M. Kubo, Y. Nishimura, M. Shingai, W. Lee, J. Brenchley, B. Lafont, A. Buckler-White, T. Igarashi, and M.A. Martin Initiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent disease J Virol 83 2009 7099 7108
15. Y. Nishimura, T. Igarashi, A. Buckler-White, C. Buckler, H. Imamichi, R.M. Goeken, W.R. Lee, B.A. Lafont, R. Byrum, and H.C. Lane Loss of naive cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques J Virol 81 2007 893 902 (Pubitemid 46067914)
16. J. Liu, B.F. Keele, H. Li, S. Keating, P.J. Norris, A. Carville, K.G. Mansfield, G.D. Tomaras, B.F. Haynes, and D. Kolodkin-Gal Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys J Virol 84 2010 10406 10412
17. B.F. Keele, H. Li, G.H. Learn, P. Hraber, E.E. Giorgi, T. Grayson, C. Sun, Y. Chen, W.W. Yeh, and N.L. Letvin Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1 J Exp Med 206 2009 1117 1134
18. B.F. Keele, E.E. Giorgi, J.F. Salazar-Gonzalez, J.M. Decker, K.T. Pham, M.G. Salazar, C. Sun, T. Grayson, S. Wang, and H. Li Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection Proc Natl Acad Sci USA 105 2008 7552 7557 (Pubitemid 351830056)
19. C.J. Miller, M. Marthas, J. Torten, N.J. Alexander, J.P. Moore, G.F. Doncel, and A.G. Hendrickx Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia J Virol 68 1994 6391 6400 (Pubitemid 24294889)
20. Z.M. Ma, K. Abel, T. Rourke, Y. Wang, and C.J. Miller A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations J Virol 78 2004 14048 14052 (Pubitemid 39612802)
21. R.S. Veazey, M. DeMaria, L.V. Chalifoux, D.E. Shvetz, D.R. Pauley, H.L. Knight, M. Rosenzweig, R.P. Johnson, R.C. Desrosiers, and A.A. Lackner Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection Science 280 1998 427 431 (Pubitemid 28208163)
22. R.S. Veazey, I.C. Tham, K.G. Mansfield, M. DeMaria, A.E. Forand, D.E. Shvetz, L.V. Chalifoux, P.K. Sehgal, and A.A. Lackner Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo J Virol 74 2000 57 64 (Pubitemid 30002883)
23. J.J. Mattapallil, D.C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection Nature 434 2005 1093 1097 (Pubitemid 40663481)
24. Y. Nishimura, T. Igarashi, O.K. Donau, A. Buckler-White, C. Buckler, B.A. Lafont, R.M. Goeken, S. Goldstein, V.M. Hirsch, and M.A. Martin Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses Proc Natl Acad Sci USA 101 2004 12324 12329 (Pubitemid 39145442)
25. T. Igarashi, Y. Endo, G. Englund, R. Sadjadpour, T. Matano, C. Buckler, A. Buckler-White, R. Plishka, T. Theodore, and R. Shibata Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus Proc Natl Acad Sci USA 96 1999 14049 14054
26. S.V. Joag, Z. Li, L. Foresman, E.B. Stephens, L.J. Zhao, I. Adany, D.M. Pinson, H.M. McClure, and O. Narayan Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques J Virol 70 1996 3189 3197 (Pubitemid 26121937)
27. K.A. Reimann, J.T. Li, R. Veazey, M. Halloran, I.W. Park, G.B. Karlsson, J. Sodroski, and N.L. Letvin A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys J Virol 70 1996 6922 6928 (Pubitemid 26307405)
28. J.A. Zack, S.J. Arrigo, S.R. Weitsman, A.S. Go, A. Haislip, and I.S. Chen HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure Cell 61 1990 213 222
29. D. Zagury, J. Bernard, R. Leonard, R. Cheynier, M. Feldman, P.S. Sarin, and R.C. Gallo Long-term cultures of HTLV-III - infected T cells: a model of cytopathology of T-cell depletion in AIDS Science 231 1986 850 853 (Pubitemid 16213045)
30. Y. Nishimura, C.R. Brown, J.J. Mattapallil, T. Igarashi, A. Buckler-White, B.A. Lafont, V.M. Hirsch, M. Roederer, and M.A. Martin Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques Proc Natl Acad Sci USA 102 2005 8000 8005 (Pubitemid 40781052)
31. Q. Li, L. Duan, J.D. Estes, Z.M. Ma, T. Rourke, Y. Wang, C. Reilly, J. Carlis, C.J. Miller, and A.T. Haase Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells Nature 434 2005 1148 1152 (Pubitemid 40663495)
32. Y. Nishimura, R. Sadjadpour, J.J. Mattapallil, T. Igarashi, W. Lee, A. Buckler-White, M. Roederer, T.W. Chun, and M.A. Martin High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections Proc Natl Acad Sci USA 106 2009 8015 8020
33. M. Di Mascio, C.H. Paik, J.A. Carrasquillo, J.S. Maeng, B.S. Jang, I.S. Shin, S. Srinivasula, R. Byrum, A. Neria, and W. Kopp Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates Blood 114 2009 328 337
34. V.V. Ganusov, and R.J. De Boer Do most lymphocytes in humans really reside in the gut? Trends Immunol 28 2007 514 518 (Pubitemid 350110424)
35. J. Westermann, and R. Pabst Distribution of lymphocyte subsets and natural killer cells in the human body Clin Investig 70 1992 539 544
36. J.D. Lifson, J.L. Rossio, R. Arnaout, L. Li, T.L. Parks, D.K. Schneider, R.F. Kiser, V.J. Coalter, G. Walsh, and R.J. Imming Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment J Virol 74 2000 2584 2593 (Pubitemid 30117567)
37. J.R. Mascola, G. Stiegler, T.C. VanCott, H. Katinger, C.B. Carpenter, C.E. Hanson, H. Beary, D. Hayes, S.S. Frankel, and D.L. Birx Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies Nat Med 6 2000 207 210 (Pubitemid 30082367)
38. Y. Nishimura, T. Igarashi, N. Haigwood, R. Sadjadpour, R.J. Plishka, A. Buckler-White, R. Shibata, and M.A. Martin Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies J Virol 76 2002 2123 2130 (Pubitemid 34150679)
39. P.W. Parren, P.A. Marx, A.J. Hessell, A. Luckay, J. Harouse, C. Cheng-Mayer, J.P. Moore, and D.R. Burton Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro J Virol 75 2001 8340 8347 (Pubitemid 32743706)
40. R. Shibata, T. Igarashi, N. Haigwood, A. Buckler-White, R. Ogert, W. Ross, R. Willey, M.W. Cho, and M.A. Martin Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys Nat Med 5 1999 204 210 (Pubitemid 29068528)
41. Y. Nishimura, T. Igarashi, N.L. Haigwood, R. Sadjadpour, O.K. Donau, C. Buckler, R.J. Plishka, A. Buckler-White, and M.A. Martin Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development Proc Natl Acad Sci USA 100 2003 15131 15136 (Pubitemid 37518028)
42. M.A. Nowak, A.L. Lloyd, G.M. Vasquez, T.A. Wiltrout, L.M. Wahl, N. Bischofberger, J. Williams, A. Kinter, A.S. Fauci, and V.M. Hirsch Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection J Virol 71 1997 7518 7525 (Pubitemid 27391692)
43. M.A. Stafford, L. Corey, Y. Cao, E.S. Daar, D.D. Ho, and A.S. Perelson Modeling plasma virus concentration during primary HIV infection J Theor Biol 203 2000 285 301
44. A.R. Stacey, P.J. Norris, L. Qin, E.A. Haygreen, E. Taylor, J. Heitman, M. Lebedeva, A. DeCamp, D. Li, and D. Grove Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections J Virol 83 2009 3719 3733
45. S. Lindback, A.C. Karlsson, J. Mittler, A. Blaxhult, M. Carlsson, G. Briheim, A. Sonnerborg, and H. Gaines Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group AIDS 14 2000 2283 2291
46. S. Lindback, R. Thorstensson, A.C. Karlsson, M. von Sydow, L. Flamholc, A. Blaxhult, A. Sonnerborg, G. Biberfeld, and H. Gaines Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group AIDS 14 2000 2333 2339
47. M.H. Katz, and J.L. Gerberding Management of occupational and nonoccupational postexposure HIV prophylaxis Curr HIV/AIDS Rep 1 2004 159 165